Understanding another acute respiratory distress syndrome.
Zimmerman
Jerry J
JJ
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000633:toxicity*; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D054360:Chemokine CXCL1; D019743:Chemokines, CXC / Q000502:physiology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects* / Q000502:physiology; D004847:Epithelial Cells / Q000187:drug effects / Q000276:immunology; D005434:Flow Cytometry; D006801:Humans; D066298:In Vitro Techniques; D016209:Interleukin-8 / Q000502:physiology*; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000276:immunology; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000276:immunology; D012128:Respiratory Distress Syndrome / Q000139:chemically induced* / Q000276:immunology; D013577:Syndrome; D014212:Tretinoin / Q000008:administration & dosage / Q000633:toxicity*
D000970:Antineoplastic Agents; C475829:CXCL1 protein, human; D054360:Chemokine CXCL1; D019743:Chemokines, CXC; D016209:Interleukin-8; D014212:Tretinoin